This paper aims to bridge formulation and process considerations along with patent reviews and may provide further insight into understanding the science and the white space.
For example, as an example of the interplay between problem formulation and biological considerations, discussions between risk assessors and research scientists can improve the efficiency of risk assessments by focusing resources on tiered and/or targeted approaches that are more efficient and reduce animal use (Meek, 2008; Meek & Klaunig, 2010), as envisioned by NRC (2007a).
Risk assessments should however be carried out in each individual case and consideration given to the particular drug formulations prescribed.
For effective implementation of the MTP, the above-mentioned barriers must be taken into consideration during policy formulation and should be addressed during implementation.
The model formulation allows consideration of arbitrary boundary value specifications and also, for some cases, spatially varying initial concentration profiles.
Finally, the Quality-by-Design considerations for tablet formulation and process development in terms of lubrication are discussed.
Summarizing the formulation with consideration of boundary condition, we can obtain the estimates of Z ij (1, 2 corresponding to x, y, respectively) with the υ0X sin I and υ0Y as the x and y components of input, respectively, as (6) (7) and hence (8) (9) where and.
However, several considerations regarding the stability, formulation, and efficacy have to be faced up until these systems could be considered to be a marketable pharmaceutical products for to extend siRNA application to clinical practice.
Of course, guideline formulation and policy-making are deliberative processes, designed for careful consideration and durability of effect rather than for speed.
